Lv2
138 积分 2024-10-31 加入
a trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
3天前
已完结
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non–Small Cell Lung Cancer
16天前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
16天前
已完结
Development and safety of investigational and approved drugs targeting the RAS function regulation in RAS mutant cancers
1个月前
已完结
Blocking T Cell Co-Stimulation Via CD70 As a Target for Gvhd in Allogeneic Stem Cell Transplantation (SCT)
1个月前
已关闭
Engineering Biodegradable Hollow Silica/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the “Ferroptosis Storm”
1个月前
已完结
Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax
4个月前
已完结
MP0533, a CD3-Engaging Darpin Targeting CD33, CD123, and CD70 in Patients with Relapsed/Refractory AML or MDS/AML: Preliminary Results of a Phase 1/2a Study
4个月前
已完结
MP0533, a CD3-Engaging Darpin Targeting CD33, CD123, and CD70 in Patients with Relapsed/Refractory AML or MDS/AML: Preliminary Results of a Phase 1/2a Study
4个月前
已关闭
CD33-Deleted Hematopoietic Cells (Trem-Cel) Are Protected from CD33xCD3 Bispecific Antibody Treatment and Produce Significantly Reduced Levels of Inflammatory Cytokines in Preclinical Studies
4个月前
已关闭
皖公网安备34019202002308
